SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to redefine how the world detects, tracks, and responds to outbreaks. STAgora™ provides real-time global visualization of infectious

SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to redefine how the world detects, tracks, and responds to outbreaks. STAgora™ provides real-time global visualization of infectious

أظهر تحليل STAgora™ لنحو 60,000 نتيجة اختبار جُمعت على مدى 42 شهرًا أن مسببات العدوى المنقولة جنسيًا رُصدت في 82% من الحالات الإيجابية لفيروس الورم الحليمي البشري تدعم النتائج القيمة المحتملة لنهج شامل للاختبارات يوفر معلومات عن فيروس الورم الحليمي البشري ومسببات العدوى المنقولة جنسيًا تعتزم سيجين التحقق من الفائدة السريرية للاختبارات الشاملة لفيروس الورم [...] The post تقترح سيجين نهجًا شاملًا لاختبارات عدوى الجهاز التناسلي من خلال دراسة المليون السريرية العالمية (GMCS) appeared first on اليوم السابع - Alyoum Alsabea.

– France becomes Seegene’s ninth overseas sales subsidiary and third in Europe, following Italy and Germany – The country ranks as Europe’s second-largest molecular diagnostics market, driven by demand in sexually transmitted infections and gastrointestinal testing, and respiratory virus detection. – The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, […]

Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data – STAgora™, the big data platform set to transform the future of diagnostics Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end SEOUL, South Korea , […] The post Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025 first appeared on Asia News Today.

Seegene Inc., pemimpin pasar diagnostik molekuler di dunia, melansir dua teknologi baru di ADLM 2025 yang berlangsung di Chicago (29-31 Juli). Kedua teknologi ...

Seegene Inc., pemimpin pasar diagnostik molekuler (molecular diagnostics/MDx) di dunia, hari ini meluncurkan STAgora™, platform generasi baru yang ...

SEÚL, Corea del Sur, 7 de julio de 2025 /PRNewswire/ -- Seegene Inc., líder mundial en soluciones de diagnóstico molecular (MDx), ha anunciado hoy el lanzamiento de STAgora™, una plataforma de nueva generación para el análisis de enfermedades infecciosas. Diseñada como un sistema de inteligencia en tiempo real sobre enfermedades infecciosas, la plataforma combina datos de diagnóstico con modelos estadísticos avanzados y pretende redefinir la forma en que el mundo detecta, rastrea y responde a los brotes.

Seegene Inc. embarks on a comprehensive approach to testing reproductive tract infections through its Global Million Clinical Study, leveraging innovative data analysis.

Explore Seegene's comprehensive strategy for diagnosing reproductive tract infections, showcased through the Global Million Clinical Study, revealing significant insights.

At ESCMID Global 2026, Seegene introduced STAgora, a platform enhancing real-time data analysis with automated PCR workflows, impressing healthcare professionals worldwide.

Discover Seegene's innovative approach to integrating real-time data analysis with automated PCR workflows, introduced at ESCMID Global 2026.

At ESCMID Global 2026, Seegene highlighted STAgora™, a groundbreaking platform for real-time data analysis integrated with automated PCR workflows, attracting global health professionals.

Seegene Inc. presents its STAgora™ platform at ESCMID Global 2026, showcasing real-time data analysis and advanced PCR workflows to revolutionize molecular diagnostics.

Seegene introduces STAgora, a pioneering real-time data platform enhancing PCR workflows, fostering global health insights at ESCMID Global 2026.

Seegene has introduced STAgora, a groundbreaking real-time data analytics platform that enhances automated PCR workflows, showcased at ESCMID 2026 in Munich.

Seegene Inc. has launched a new subsidiary in France, enhancing its presence in Europe, focusing on diagnostics and local partnerships.

Seegene, a leader in molecular diagnostics, establishes a new subsidiary in France to enhance its presence in Europe and accelerate product adoption.

Seegene has announced the inauguration of a new sales branch in France, aiming to reinforce its presence in the European market and support global expansion.

Seegene, a leader in molecular diagnostics, announced its new subsidiary in France, enhancing its European presence and market share.

Seegene Inc. showcases its innovations, CURECA™ and STAgora™, at ADLM 2025, significantly enhancing diagnostic automation and disease monitoring.

Seegene Inc. introduces groundbreaking technologies CURECA™ and STAgora™ at the ADLM 2025 conference, shifting the future of diagnostic testing.

At ADLM 2025, Seegene unveiled two groundbreaking technologies, CURECA™ and STAgora™, focused on revolutionizing molecular diagnostics and disease monitoring.

At the recent ADLM 2025 in Chicago, Seegene unveiled CURECA™ and STAgora™, innovative technologies aimed at enhancing molecular diagnostics through automation and real-time data analysis.

Seegene, a leader in molecular diagnostics, showcases its innovative CURECA™ and STAgora™ technologies at ADLM 2025 in Chicago, revolutionizing diagnostic automation.